Jun 26, 2023

J.P. Morgan

January 2019:

ARTHEx S.L. participation at the 37th Annual J.P. Morgan Healthcare Conference, celebrated from January 7 to 10 2019 in San Francisco, California.

‍

Continue reading

ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024

ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024

This is some text inside of a div block.

by

ARTHEx Biotech Announces Participation at the 23rd Annual Needham Virtual Healthcare Conference

ARTHEx Biotech Announces Participation at the 23rd Annual Needham Virtual Healthcare Conference

This is some text inside of a div block.

by

February 28, 2024

ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

This is some text inside of a div block.

by